When you’re dealing with stiff, achy or swollen joints, arthritis flare-ups can be painful and tough to manage. Even if you know these symptoms are temporary, you may still feel compelled to make some ...

The U.S. Food and Drug Administration has approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis. Sotyktu is an oral, selective tyrosine kinase 2 inhibitor and ...

In the POETYK PsA-1 and PsA-2 phase 3 trials, deucravacitinib demonstrated superior efficacy over placebo in achieving ACR20 response at week 16. The Food and Drug Administration (FDA) has approved ...

Psoriatic arthritis (PsA) is an autoimmune disease that causes inflammation of the joints, tendons, and nails. It usually occurs in people with psoriasis, an inflammatory condition causing rashes on ...

Researchers have figured out how psoriasis can quietly turn into joint disease for some patients. Immune cells formed in inflamed skin can travel through the blood and reach the joints, where they ...

Michelle Spear does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

As of 2021, about 17.9 million people around the world were living with rheumatoid arthritis, an autoimmune disease causing inflammation, pain, and swelling in the joints. There is also currently no ...

Philip Mease, MD, discusses the different treatment options now available for patients with psoriasis and psoriatic arthritis. Psoriatic arthritis (PsA) affects roughly 30% of patients with psoriasis, ...

ORLANDO, Fla. (Ivanhoe Newswire) - Osteoarthritis is the most common type of arthritis — affecting about 32.5 million Americans. It happens when cartilage that cushions bone wears out over time. It ...

As evidence of tirzepatide’s efficacy mounts across a range of cardiometabolic conditions, Eli Lilly has shown that taking the incretin medicine alongside another of its drugs, Taltz, could lead to ...